SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008135
Filing Date
2024-05-14
Accepted
2024-05-14 16:10:34
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20240331x10q.htm   iXBRL 10-Q 700434
2 EX-31 bpth-20240331xex31.htm EX-31 12489
3 EX-32 bpth-20240331xex32.htm EX-32 6286
  Complete submission text file 0001558370-24-008135.txt   3251647

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20240331.xsd EX-101.SCH 29778
5 EX-101.CAL bpth-20240331_cal.xml EX-101.CAL 30587
6 EX-101.DEF bpth-20240331_def.xml EX-101.DEF 116615
7 EX-101.LAB bpth-20240331_lab.xml EX-101.LAB 222517
8 EX-101.PRE bpth-20240331_pre.xml EX-101.PRE 204476
57 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20240331x10q_htm.xml XML 318248
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 24944429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)